These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31891754)

  • 1. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents.
    Santos NAGD; Ferreira RS; Santos ACD
    Food Chem Toxicol; 2020 Feb; 136():111079. PubMed ID: 31891754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
    Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
    Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.
    Mukherjea D; Dhukhwa A; Sapra A; Bhandari P; Woolford K; Franke J; Ramkumar V; Rybak L
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):965-982. PubMed ID: 32757852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
    Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
    Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. d-Methionine protects against cisplatin-induced neurotoxicity in cortical networks.
    Gopal KV; Wu C; Shrestha B; Campbell KC; Moore EJ; Gross GW
    Neurotoxicol Teratol; 2012; 34(5):495-504. PubMed ID: 22732230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity.
    Paciello F; Fetoni AR; Mezzogori D; Rolesi R; Di Pino A; Paludetti G; Grassi C; Troiani D
    Sci Rep; 2020 Jan; 10(1):1063. PubMed ID: 31974389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy.
    Santabarbara G; Maione P; Rossi A; Gridelli C
    Expert Opin Pharmacother; 2016; 17(4):561-70. PubMed ID: 26581586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Update on the Protective Potentials of Resveratrol against Cisplatin-induced Ototoxicity: A Systematic Review.
    Alsaikhan F; Jasim SA; Margiana R; Opulencia MJC; Yasin G; Hammid AT; Nasretdinova MT; Mahdi AB; Farhood B; Abedi-Firouzjah R; Jamialahmadi T; Sahebkar A
    Curr Med Chem; 2024; 31(30):4850-4866. PubMed ID: 37491852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
    Freyer DR; Brock P; Knight K; Reaman G; Cabral S; Robinson PD; Sung L
    Lancet Child Adolesc Health; 2019 Aug; 3(8):578-584. PubMed ID: 31160205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.
    Freyer DR; Brock PR; Chang KW; Dupuis LL; Epelman S; Knight K; Mills D; Phillips R; Potter E; Risby D; Simpkin P; Sullivan M; Cabral S; Robinson PD; Sung L
    Lancet Child Adolesc Health; 2020 Feb; 4(2):141-150. PubMed ID: 31866182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of misoprostol against cisplatin-induced ototoxicity.
    Doğan M; Polat H; Yaşar M; Kaya A; Bayram A; Şenel F; Özcan İ
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3685-3692. PubMed ID: 27052552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic vulnerability to cisplatin ototoxicity: a systematic review.
    Tserga E; Nandwani T; Edvall NK; Bulla J; Patel P; Canlon B; Cederroth CR; Baguley DM
    Sci Rep; 2019 Mar; 9(1):3455. PubMed ID: 30837596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of cisplatin-induced ototoxicity in adults: A systematic review.
    Correa-Morales JE; Giraldo-Moreno S; Mantilla-Manosalva N; Cuellar-Valencia L; Borja-Montes OF; Bedoya-Muñoz LJ; Iriarte-Aristizábal MF; Quintero-Muñoz E; Zuluaga-Liberato AM
    Clin Otolaryngol; 2024 Jan; 49(1):1-15. PubMed ID: 37818931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial.
    Sarafraz Z; Ahmadi A; Daneshi A
    Int Tinnitus J; 2018 Jun; 22(1):40-45. PubMed ID: 29993216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Chemoprotective Potentials of Alpha-lipoic Acid against Cisplatin-induced Ototoxicity: A Systematic Review.
    Lateef Al-Awsi GR; Arshed U; Arif A; Ramírez-Coronel AA; Alhassan MS; Mustafa YF; Rahman FF; Zabibah RS; Gupta J; Iqbal MS; Iswanto AH; Farhood B
    Curr Med Chem; 2024; 31(23):3588-3603. PubMed ID: 37165582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
    Bokemeyer C; Berger CC; Hartmann JT; Kollmannsberger C; Schmoll HJ; Kuczyk MA; Kanz L
    Br J Cancer; 1998 Apr; 77(8):1355-62. PubMed ID: 9579846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity.
    Duval M; Daniel SJ
    J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):309-15. PubMed ID: 23092832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of cisplatin ototoxicity and progress in otoprotection.
    Rybak LP
    Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):364-9. PubMed ID: 17823555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.